Zomedica Pharmaceuticals Corp Asset Resilience Ratio

Latest as of March 2025: 38.30%

Zomedica Pharmaceuticals Corp asset resilience ratio. Zomedica Pharmaceuticals Corp (ZOM) has an Asset Resilience Ratio of 38.30% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how many days can Zomedica Pharmaceuticals Corp fund operations to measure how many days the company can operate on defensive assets alone.

Liquid Assets

$54.77 Million

Cash + Short-term Investments

Total Assets

$142.99 Million

All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio of Zomedica Pharmaceuticals Corp (2015–2024)

Asset resilience ratio of Zomedica Pharmaceuticals Corp from 2015 to 2024. This chart shows how Zomedica Pharmaceuticals Corp's Asset Resilience Ratio has changed over time. Read Zomedica Pharmaceuticals Corp balance sheet liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Zomedica Pharmaceuticals Corp's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see ZOM current and non-current assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$54.77 Million	38.3%
Total Liquid Assets	$54.77 Million	38.30%

Asset Resilience Insights

Very High Liquidity: Zomedica Pharmaceuticals Corp maintains exceptional liquid asset reserves at 38.30% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Zomedica Pharmaceuticals Corp Industry Peers by Asset Resilience Ratio

Compare Zomedica Pharmaceuticals Corp's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Shenzhen New Industries Biomedical SHE:300832	Medical Devices	9.95%
GN Store Nord CO:GN	Medical Devices	-4.56%
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A SHG:688212	Medical Devices	6.09%
Polynovo Ltd AU:PNV	Medical Devices	0.04%
L&C Bio Co. Ltd KQ:290650	Medical Devices	2.14%
VIROMED MEDICAL NA O.N. XETRA:VME	Medical Devices	0.03%
Affluent Medical SAS PA:AFME	Medical Devices	0.03%
DRGEM Corporation KQ:263690	Medical Devices	2.12%

Zomedica Pharmaceuticals Corp Asset Resilience Ratio by Year (2015–2024)

Zomedica Pharmaceuticals Corp asset resilience ratio by year from 2015 to 2024. The table below shows the annual Asset Resilience Ratio data for Zomedica Pharmaceuticals Corp.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	31.02%	$64.33 Million	$207.36 Million	+0.40pp
2023-12-31	30.63%	$77.55 Million	$253.20 Million	-10.54pp
2022-12-31	41.16%	$115.09 Million	$279.61 Million	-28.37pp
2021-12-31	69.53%	$194.95 Million	$280.40 Million	-24.20pp
2020-12-31	93.72%	$61.99 Million	$66.14 Million	+56.82pp
2019-12-31	36.91%	$1.54 Million	$4.18 Million	-16.09pp
2018-12-31	53.00%	$3.20 Million	$6.03 Million	-24.04pp
2017-12-31	77.04%	$4.02 Million	$5.22 Million	+10.86pp
2016-12-31	66.18%	$3.23 Million	$4.88 Million	--
2015-12-31	0.00%	$0.00	$3.86 Million	--

pp = percentage points

About Zomedica Pharmaceuticals Corp

NYSE MKT:ZOM USA Medical Devices

Market Cap

$53.90 Million

Market Cap Rank

#21444 Global

#4812 in USA

Share Price

$0.06

Change (1 day)

+0.00%

52-Week Range

$0.06 - $0.06

All Time High

$2.98